ANTIDIABETIC AND BIOLOGICAL ACTIVITIES OF NICOTIANA TABACUM: POSSIBLE MECHANISMS

  • OLUWAFEMI OMONIYI OGUNTIBEJU Department of Biomedical Sciences, Phytomedicine and Phytochemistry Group, Oxidative Stress Research Centre, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Bellville 7535, South Africa.

Abstract

Diabetes mellitus is a growing global health problem. Reports predicted that diabetes mellitus could reach a pandemic level affecting people in both developing and developed countries. According to the World Health Organization, high blood glucose is seen as the third highest risk factor for premature mortality in diabetics. For several thousands of years before the adventure of orthodox medications, human beings have been using medicinal plants in the treatment of various disease conditions such as cancer, cardiovascular disease, infertility, bacterial, viral infections, and diabetes mellitus. The beneficial effects of selected medicinal therapies in the treatment and management of diabetes and diabetic complications have been reported. Many medicinal plants across Africa and Asia are known for their rich phytochemicals with effective components that have been observed to effectively reduce high blood glucose either in diabetic persons or diabetes-induced animals. The motivation for the use of medicinal plants includes availability, affordability, knowledge, effectiveness, and safety and some are of the opinion that medicinal plants and their derivatives could be effective and safe alternative treatment for diabetes and diabetic complications. Nicotiana tabacum is one of those plants with antidiabetic and pharmacological potentials which could benefit humans and animals if appropriately utilized; however, less attention has been focused on its antidiabetic properties. In fact, there is a paucity of information on the antidiabetic activities of N. tabacum. Therefore, this paper examines the antidiabetic and other biological activities of N. tabacum.

Keywords: Medicinal plants, Antimicrobial activity, Diabetes mellitus, Human health, Animal health

References

1. De Wet B. Medicinal plants and human health. S Afri Pharm J 2011;78:38-40.
2. Goboza M, Aboua YG, Chegou N, Oguntibeju OO. Vindoline effectively ameliorated diabetes-induced hepatotoxicity by docking oxidative stress, inflammation and hypertriglyceridemia in Type 2 diabetes-induced male Wistar rats. Biomed Pharmacother 2019;112:108638.
3. Abo KA, Fred-Jaiyesimi AA, Jaiyesimi AE. Ethnobotanical studies of medicinal plants used in the management of diabetes mellitus in South Western Nigeria. J Ethnopharmacol 2008;115:67-71.
4. Agbonon A, Eklu-Gadegbeku K, Aklikokou K, Gbeassor M, Akpagana K, Tam TW, et al. In vitro inhibitory effect of West African medicinal and food plants on human cytochrome P450 3A subfamily. J Ethnopharmacol 2010;128:390-4.
5. Masola B, Oguntibeju OO, Oyenihi AB. Centella asiatica ameliorates diabetes-induced stress in rat tissues via influences on antioxidants and inflammatory cytokines. Biomed Pharmacother 2018;101:447-57.
6. Rawat A, Mali RR. Phytochemical propertieis and pharmacological activities of Nicotiana tabacum. Indian J Pharm Biol Res 2013;1:74-82.
7. Kishore K. Monograph of Nicotiana tabacum. Indian J Drugs 2014;2:5-23.
8. Groark PK. Therapeutic and protective uses of Nicotiana tabacum among the Tzeltal and Tzotzil Maya of Chiapas, Mexico. J Ethnobiol 2010;30:5-30.
9. Ezeja MI, Omeh SY. Nociceptive activity of the methanolic leaf of Nicotiana tabacum. Wilolud J 2010;3:5-10.
10. Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 2002;161:97-104.
11. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Belgium: International Diabetes Federation; 2017. p. 1-150.
12. World Health Organization. Global Report on Diabetes. Geneva: World Health Organization; 2016.
13. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018;138:271-81.
14. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-70.
15. Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. World J Mens Health 2014;32:1-7.
16. Albert O, Desdoits-Lethimonier C, Lesné L, Legrand A, Guillé F, Bensalah K, et al. Paracetamol, aspirin and indomethacin display endocrine disrupting properties in the adult human testis in vitro. Hum Reprod 2013;28:1890-8.
17. Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009;7:65-74.
18. Sharma P, Jha AB, Dubey RS, Pessarakli M. Reactive oxygen species, oxidative damage and antioxidative defence mechanism in plants under stressful conditions. J Bot 2012;56:1-26.
19. Onyeyili PA, Nwosu CO, Amin JD, Jibike JI. Anthelmintic activity of crude aqueous extract of Nauclea latifolia stem bark against ovine nematodes. Fitoterapia 2001;72:12-21.
20. Jain GC, Jangir RN. Modulation of diabetes-mellitus-induced male reproductive dysfunctions in experimental animal models with medicinal plants. Pharmacogn Rev 2014;8:113-21.
21. Petroianu A, Alberti LR, de Melo MA, de Almeida M. Relationship between diabetes mellitus and male fertility. Einstein 2009;7:407-10.
22. Amaral S, Oliveira PJ, Ramalho-Santos J. Diabetes and the impairment of reproductive function: Possible role of mitochondria and reactive oxygen species. Curr Diabetes Rev 2008;4:46-54.
23. Cernea S, Dobreanu M. Diabetes and beta cell function: From mechanisms to evaluation and clinical implications. Biochem Med (Zagreb) 2013;23:266-80.
24. Kazeem MI, Oyedapo BF, Raimi OG, Adu OB. Evaluation of Ficus exasperta Vavi leaf extracts in the management of diabetes mellitus in vitro. J Med Sci 2013;13:269-75.
25. Kazeem MI. In vitro study on the hypoglycaemic potential of Nicotiana tabacum leaf extracts. Bangladesh J Pharmacol 2014;9:140-5.
26. Sofowora A. Medicinal plants and traditional medicine in Africa. Ibadan, Nigeria: Spectrum Books Ltd.; 2006. p. 191-289.
27. McCue PP, Shetty K. Inhibitory effects of rosmarinic acid extracts on porcine pancreatic amylase in vitro. Asia Pac J Clin Nutr 2004;13:101-6.
28. Ali H, Houghton PJ, Soumyanath A. Alpha-amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol 2006;107:449-55.
29. Kwon YI, Apostolidis E, Shetty K. Inhibitory potential of wine and tea against alpha-amylase for management of hyperglycaemia linked to Type 2 diabetes. J Food Biochem 2008;32:15-31.
30. Song W, Wang HJ, Bucheli P, Zhang PF, Wei DZ, Lu YH. Phytochemical profiles of different mulberry (Morus sp.) species from China. J Agric Food Chem 2009;57:9133-40.
31. Oguntibeju OO, Meyer S, Aboua YG, Goboza M. Hypoxis hemerocallidea significantly reduced hyperglycaemia and hyperglycaemic-induced oxidative stress in the liver and kidney tissues of streptozotocin-induced diabetic male Wistar rats. Evid Based Complement Alternat Med 2016;2016:8934362.
32. Oguntibeju OO. The potential protective effects of selected medicinal plants on liver function and integrity. Afr J Biomed Res 2018;21:231-6.
33. Emordi JE, Agbaje EO, Oreagba LA, Iribhogbe IO. Preliminary phytochemical screening and evaluation of hypoglycaemic properties of the root extract of Uveria chamae. Bangladesj J Pharmacol 2015;10:326-31.
34. Shang Q, Xiang J, Zhang H, Li Q, Tang Y. The effect of polyhydroxylated alkaloids on maltase-glucpamylase. PLoS One 2013;8:1-5.
35. Malik R, Siddiqui TZ, Siddiqui MF, Younis U, Hussain MI, Khan IA. Antimicrobial activity of Nerium oleander L and Nicotina tabacum: A comparative study. Pak J Bot 2015;47:1587-92.
36. Adeleye A, Onubogu CC, Ayolabi CI. Screening of 12 extracts of medicinal plants and wonder cure concoction used in Nigeria unorthodox medicine for activity against tuberculosis patients’ sputum. Afri J Biotech 2008;7:3182-7.
37. Iqbal Z, Lateef M, Jabbar A, Ghayur MN, Gilani AH. In vitro and In vivo anthelmintic activity of Nicotiana tabacum L. leaves against gastrointestinal nematodes of sheep. Phytother Res 2006;20:46-8.
38. Oyenihi OR, Brooks NL, Oguntibeju O. Effects of kolavin on hepatic oxidative stress in streptozotocin induced diabetes. BMC Complement Altern Med 2015;15:236.
39. Sen S, Chakraborty R, Bipab D. Challenges and opportunities in the advancement of herbal medicine: India’s position and role in a global context. J Her Med 2011;1:67-75.
40. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007;40:163-73.
41. Abdurrazak M, Rao MU, Ado AB, Mohd KS, Zin T. Some natural products and their secondary metabolites attributed towards diabetic cure: A review. Int J Pharm Pharm Sci 2015;7:22-8.
42. Hanene G, Aouadhi C, Hamrouni S, Mnif W. Antibacterial, antifungal and antioxidant activities of Tunisan Olea europaea spp, oleaster fruit pulp and its essential fatty acids. Int J Pharm Pharm Sci 2015;7:52-5.
43. Ponstein AS, Bres-Vloemans SA, Buurlage MB. Novel pathogen and wound-inducible Nicotiana protein with antifungal activity. Plant Physiol 1994;104:109-18.
44. Scerri C. Nicotine: Pharmacology and therapeutic implications in neurodegenerative and psychiatric disorders. Malta Med J 2005;1:17-21.
45. Balfour DJ, Fagerstrom KO. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodebgenerative disorders. Pharmacol Ther 1996;66:137-47.
46. Francis P, Palmer A, Snape M, Wilcock G. The cholinergic hypothesis of alzheimers disease. J Neurol Neurosurg Pyschiatry 1999;66:137-47.
47. Khalifa AE. Hypericum perforatum as a nootropic drug: Enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. J Ethnopharmacol 2001;76:49-57.
Statistics
222 Views | 205 Downloads
Citatons
How to Cite
OGUNTIBEJU, O. O. “ANTIDIABETIC AND BIOLOGICAL ACTIVITIES OF NICOTIANA TABACUM: POSSIBLE MECHANISMS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 3, Jan. 2020, pp. 1-4, doi:10.22159/ajpcr.2020.v13i3.35546.
Section
Review Article(s)